The Patent Finder

Glenmark Pharmaceuticals Limited

Also on record
Records under this name other than the patents Glenmark Pharmaceuticals Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Back to Glenmark Pharmaceuticals Limited

PatentTitleStatus Expires Confidence
US 8,097,729Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US D795,414Inhaler
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,227,958Amorphous and crystalline forms of aprepitant and processes for the preparation thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,670,160Process for the preparation of tofacitinib and intermediates thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,550,735Process for the preparation of ivacaftor and solvates thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,078,923Stable Fixed Dose Pharmaceutical Composition Comprising Mometasone and Olopatadine
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,370,483Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,646,500Treatment of Allergic Rhinitis Using a Combination of Mometasone and Olopatadine
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,840,456Process for preparation of dimethyl fumarate
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,548,907Treatment of allergic rhinitis using a combination of mometasone and olopatadine
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 46 patents shown.
Pro members see all 46.
Pro members: see all 46 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited